Daily subQ dose (guides)
Timing and details
Loading…
Also known as: Kisspeptin-10 · KP-10 · Kisspeptin 10 · Metastin 45-54 · Kisspeptin-54
Updated 20 sources
How it is thought to work. Kisspeptin binds the KISS1 receptor (GPR54) on GnRH neurons in the hypothalamus. That releases GnRH, which makes the pituitary release LH and FSH, which then drive testosterone or estrogen and sperm or egg development. Kisspeptin-10 is the shortest piece with full activity; kisspeptin-54 is the longer natural form that lasts longer in blood. Constant high exposure can blunt the response, so dose timing matters.
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Doses shown are what sources report, labelled by origin. Not medical advice.
Full Kisspeptin dosage guideEvery titration step in syringe units, missed doses and how to mix.| Water | Strength | 50 mcgdose, units | 100 mcgdose, units | 200 mcgdose, units |
|---|---|---|---|---|
| 10 mg vial | ||||
| 1 mLCompetitor guide | 10 mg/mL | 0.50.005 mLunder 1 unit | 10.01 mL | 20.02 mL |
| 1.5 mLCompetitor guide | 6.667 mg/mL | 0.80.008 mLunder 1 unit | 1.50.015 mL | 30.03 mL |
| 2 mLCompetitor guide | 5 mg/mL | 10.01 mL | 20.02 mL | 40.04 mL |
| 2.5 mLCompetitor guide | 4 mg/mL | 1.30.013 mL | 2.50.025 mL | 50.05 mL |
| 3 mLCompetitor guide | 3.333 mg/mL | 1.50.015 mL | 30.03 mL | 60.06 mL |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: Kisspeptin in syringe units, with the math shown.From clinical trials and regulatory documents.
No serious adverse events in small, short studies of about 300 people given kisspeptin-10; many studies did not report side effects at all.
In the women's HSDD trial (32 completers), kisspeptin-54 was well tolerated with no reported adverse effects.
Twice-daily kisspeptin-54 nearly abolished the FSH response by day 2 in women with hypothalamic amenorrhea. Five days of constant kisspeptin-10 brought LH and FSH back to placebo levels in men.
How people manage it
In healthy women on twice-daily kisspeptin-54, cycles averaged 26.8 days vs 28.6 on saline.
One FDA adverse event report in a teenager on compounded 100 mcg daily for six weeks. FDA said the timing and link were unclear.
No study has measured it. FDA flags immunogenicity as a risk for injected kisspeptin-10, higher under the skin than IV.
From community reports and dosing guides. Not measured rates.
Listed by one guide as occasional; no rates given.
Occasional and mild, per guides; no rates given.
How people manage it
Drug-tested sportCondition
WADA's 2026 Prohibited List bans kisspeptin and its agonist analogues in male athletes at all times (S2.2.1).
Keep the powder frozen at -20 C for long storage, dry and dark.
Keep the mixed vial at 2 to 8 C and do not freeze it. One site says use within 28 days; two others give no day count and defer to the product's own use-by date.
Mixed with: Bacteriostatic water
Mixing. 2 mL in a 10 mg vial is the default in one guide, giving 5 mg per mL. At mcg doses from a 10 mg vial, each syringe unit holds a lot of peptide, so let the calculator turn your dose into units.
Kisspeptin works upstream through the brain while hCG acts directly on the testes; community summaries describe pairing them for fertility on TRT.
Kisspeptin triggers natural GnRH release and gonadorelin is GnRH itself; some users stack both for two-step axis stimulation. No study has tested the pair.
Overlap more than synergy: PT-141 is the on-demand desire drug, kisspeptin works on the hormone axis. Melanotan II, the PT-141 parent, is among the compounds most often co-logged with kisspeptin on one site.
Not a designed stack: retatrutide is the compound most often logged alongside kisspeptin in one site's user logs.
Human data are real but small and lab-based: IV boluses and infusions of kisspeptin-10 in healthy men, a 2026 study of 12 days of subcutaneous infusions in 7 men, and kisspeptin-54 trials for IVF, amenorrhea and low sexual desire. FDA found about 300 people given kisspeptin-10, no study longer than one day of dosing at the time, and no trial of the 100 to 200 mcg shots used at home.
On FDA's list of bulk substances with significant safety concerns.
Not FDA approved for any use. Kisspeptin-10 is on FDA's 503A Category 2 list of bulk substances that raise significant safety risks, added September 29, 2023. In October 2024 FDA's compounding advisory committee voted 11 to 0 against adding it to the 503A bulks list.
WADA's 2026 list names kisspeptin and its agonist analogues under S2.2.1, testosterone-stimulating peptides in males. FDA reviewed it only for secondary hypogonadism in men and found no human studies by the intramuscular route and one single-dose subcutaneous study.
WADA: Prohibited
A hormone made in the hypothalamus that switches on the reproductive axis. It releases GnRH, which drives LH, FSH and testosterone or estrogen. Kisspeptin-10 is the short 10-amino-acid piece vendors sell; kisspeptin-54 is the longer natural form used in most fertility trials.
Guides run 100 to 200 mcg under the skin once a day, with 50 to 100 mcg as a low start. Community summaries more often describe 100 to 200 mcg two or three times a week. No trial has tested either schedule.
Mostly per-kg doses by IV: kisspeptin-10 boluses of 0.01 to 3 mcg/kg peaked at 1 mcg/kg, and infusions ran 1.5 to 4 mcg/kg per hour. Fertility trials used kisspeptin-54 at 3.2 to 12.8 nmol/kg as one injection, or 6.4 nmol/kg twice a week.
Guides use 1 to 3 mL. 2 mL gives 5 mg per mL and is one guide's default; another uses 3 mL for about 3.33 mg per mL. Enter your vial and water in the calculator to get syringe units for your dose.
Guides do not split doses by sex. In the trials here, healthy men mostly got kisspeptin-10 by IV and women in fertility trials got kisspeptin-54 under the skin, both dosed per kg of body weight.
In healthy men, a 22.5-hour IV infusion raised testosterone from 16.6 to 24.0 nmol/L. A 2026 study kept LH and testosterone up for 12 days with daily 8-hour subcutaneous infusions. Effects of home injections a few times a week have not been studied.
In two small trials, a 75-minute IV infusion of kisspeptin-54 changed brain activity to sexual images in men and women with low desire. Men also had up to 56% more penile tumescence than on placebo. These were one-visit lab studies, not home treatment.
That is a common community use, but no trial has tested it in men on TRT. Kisspeptin needs a working pituitary and GnRH system to work, and testosterone therapy itself suppresses that axis.
About 4 minutes in human blood, versus 27.6 minutes for kisspeptin-54. In rats given it by IV, it is under 1 minute. One trial team noted that kisspeptin-54, not kisspeptin-10, suits injection under the skin because it lasts longer.
Guides say yes at 100 to 200 mcg, with breaks. Trials show the catch: twice-daily kisspeptin-54 caused tolerance in women with amenorrhea, and 5 days of constant kisspeptin-10 brought LH back to baseline in men, while 8 hours on and 16 off kept working for 12 days.
Trials report few. FDA found no serious adverse events in small studies of about 300 people. Guides list mild flushing, headache, brief nausea and injection-site redness. FDA flags immune reactions and impurities as unstudied risks for compounded kisspeptin-10.
No. FDA lists kisspeptin-10 in Category 2, substances that raise significant safety risks for compounding, and its advisory committee voted 11 to 0 against allowing it in October 2024.
Yes. WADA's 2026 list names kisspeptin and its agonist analogues under S2.2.1, testosterone-stimulating peptides in males.
Powder at -20 C. Once mixed, keep it at 2 to 8 C and do not freeze it. One site gives 28 days after mixing; others defer to the product label.
Both come from the same gene. Kisspeptin-54 is longer and lasts longer in blood (27.6 vs about 4 minutes), so trials could give it under the skin. Kisspeptin-10 is cheaper to make and is what vendors sell. By IV in men, both raised LH to a similar degree.
Answers come from this site's pages only, with a link to each source.
20 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.